Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis

…, M Doll, JM Kutner, JRR Pinho, LV Rizzo, JL Miraglia… - Journal of Infection, 2022 - Elsevier
Objectives We aimed to assess the short-term effectiveness of COVID-19 vaccines among
immunocompromised patients to prevent laboratory-confirmed symptomatic COVID-19 …

COVID-19 diagnosis prediction in emergency care patients: a machine learning approach

AF de Moraes Batista, JL Miraglia, TH Rizzi Donato… - MedRxiv, 2020 - medrxiv.org
The coronavirus disease (COVID-19) pandemic has increased the necessity of immediate
clinical decisions and effective usage of healthcare resources. Currently, the most validated …

Effectiveness of heterologous coronavirus disease 2019 (COVID-19) vaccine booster dosing in Brazilian healthcare workers, 2021

AR Marra, JL Miraglia, DT Malheiros… - Clinical infectious …, 2023 - academic.oup.com
Background Little is currently known about vaccine effectiveness (VE) for either 2 doses of
Oxford-AstraZeneca (ChAdOx1) viral vector vaccine or CoronaVac (Instituto Butantan) …

Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled …

…, ST Maria do Carmo, JL Miraglia… - The Lancet Infectious …, 2020 - thelancet.com
Background The Butantan Institute has manufactured a lyophilised tetravalent live-attenuated
dengue vaccine Butantan-DV, which is analogous to the US National Institutes of Health (…

Liver transplant from Anti‐HBc‐positive, HBsAg‐negative donor into HBsAg‐negative recipient: is it safe? A systematic review of the literature

…, PR Bonazzi, ATW Song, JL Miraglia… - Clinical …, 2010 - Wiley Online Library
Avelino‐Silva VI, D′Albuquerque LAC, Bonazzi PR, Song ATW, Miraglia JL, de Brito Neves
A, Abdala E. Liver transplant from Anti‐HBc‐positive, HBsAg‐negative donor into HBsAg‐…

Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease

…, CGS Saad, G Trudes, A Duarte, JL Miraglia… - The Journal of …, 2012 - jrheum.org
Objective. To assess the immunogenicity and safety of non-adjuvanted influenza A H1N1/2009
vaccine in patients with juvenile autoimmune rheumatic disease (ARD) and healthy …

[HTML][HTML] A seroprevalence survey of anti-SARS-CoV-2 antibodies among individuals 18 years of age or older living in a vulnerable region of the city of São Paulo …

JL Miraglia, C Nascimento Monteiro… - PLoS …, 2021 - journals.plos.org
A second wave of COVID-19 has demonstrated how challenging it will be to achieve sustained
control of the disease, even with vaccination underway in many countries. Therefore, it …

[HTML][HTML] Frenetic, under-challenged, and worn-out burnout subtypes among brazilian primary care personnel: Validation of the Brazilian “burnout clinical subtype …

…, A Pérez-Aranda, JL Miraglia… - International journal of …, 2020 - mdpi.com
Primary healthcare personnel show high levels of burnout. A new model of burnout has been
developed to distinguish three subtypes: frenetic, under-challenged, and worn-out, which …

[HTML][HTML] Immunogenicity and reactogenicity of 2009 influenza A (H1N1) inactivated monovalent non-adjuvanted vaccine in elderly and immunocompromised patients

JL Miraglia, E Abdala, PM Hoff, AM Luiz, DS Oliveira… - PloS one, 2011 - journals.plos.org
Background Immunosuppressed individuals present serious morbidity and mortality from
influenza, therefore it is important to understand the safety and immunogenicity of influenza …

[HTML][HTML] Distance learning in antimicrobial stewardship: innovation in medical education

M Laks, CM Guerra, JL Miraglia, EA Medeiros - BMC medical education, 2019 - Springer
Background This study aimed to analyse the impact that web-based distance learning has
on knowledge gain in medical students, as well as student perceptions of the methodology. …